Superior antimitogenic and chemosensitization activities of the combination treatment of the histone deacetylase inhibitor apicidin and proteasome inhibitors on human colorectal cancer cells

By      

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 105-128

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells

By        

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 560-564

Spandidos Publications

Access to resources Recommend Favorite

Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration

By                  

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 580-584

Spandidos Publications

Access to resources Recommend Favorite

Pro-apoptotic activity of oncogenic H-Ras for histone deacetylase inhibitor to induce apoptosis of human cancer HT29 cells

By Choudhary Shambhunath   Wang Hwa-Chain  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 10, 2007-10 ,pp. : 725-739

Springer Publishing Company

Access to resources Recommend Favorite

The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells

By Groh Tomas   Hrabeta Jan   Khalil Mohammed Ashraf   Doktorova Helena   Eckschlager Tomas   Stiborova Marie  

International Journal of Oncology, Vol. 47, Iss. 1, 2015-07 ,pp. : 343-352

Spandidos Publications

Access to resources Recommend Favorite